MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

Home・Aandelen Lijst・Evolent Health Inc

Evolent Health Inc

Gesloten

SectorGezondheidszorg

7.51 -4.09

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

7.51

Max

7.67

Belangrijke statistieken
By Trading Economics
Inkomsten	14M -51M
Verkoop	-39M 444M
Winstmarge	-11.498
Werknemers	4,500
EBITDA	43M 14M

Aanbevelingen
By TipRanks
Aanbevelingen	Strong Buy
12 Maanden Prognose	+114.21% upside

Dividenden
By Dow Jones
Volgende Winsten	6 nov 2025

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-256M 891M
Vorige openingsprijs	11.6
Vorige sluitingsprijs	7.51

Nieuwssentiment

By Acuity

61%

39%

306 / 371 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bullish Evidence

10.33 / 10.95 Steun & Weerstand

Evolent Health Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

17 okt 2025, 18:13 UTC

Belangrijke Marktbewegers

Revolution Medicines Rises as FDA Grants Priority Designation for Cancer Treatment

17 okt 2025, 17:05 UTC

Belangrijke Marktbewegers

Artiva Biotherapeutics Shares Jump After Treatment Gets Fast Tracked

18 okt 2025, 13:30 UTC

Acquisities, Fusies, Overnames

Deal Expected to Value Unit at Roughly $4B, Sources Say -- WSJ

18 okt 2025, 13:30 UTC

Acquisities, Fusies, Overnames

Deal Could Be Announced as Soon as Next Week, Sources Say -- WSJ

18 okt 2025, 13:30 UTC

Acquisities, Fusies, Overnames

Gucci Owner Kering Nears $4 Billion Sale of Beauty Unit to L'Oréal -- WSJ

18 okt 2025, 13:30 UTC

Acquisities, Fusies, Overnames

Gucci Parent Kering in Talks to Sell Beauty Business to L'Oréal, Sources Say -- WSJ

18 okt 2025, 08:20 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

18 okt 2025, 07:00 UTC

Winsten

A Growing Nimby Movement Could Upend the Data Center Boom -- Barrons.com

17 okt 2025, 23:25 UTC

Acquisities, Fusies, Overnames

New Zealand's 'Golden Visa' Targets the Affluent in Search of Plan B -- Barrons.com

17 okt 2025, 22:15 UTC

Marktinformatie

Ulta's CFO Appointment Seen Supporting Growth -- Market Talk

17 okt 2025, 21:15 UTC

Marktinformatie

Greece Expected to Post Overall Budgetary Surplus This Year -- Market Talk

17 okt 2025, 21:07 UTC

Marktinformatie

Oracle Stock Expected to Take a Breather as Capex Climbs -- Market Talk

17 okt 2025, 21:07 UTC

Marktinformatie

Global Equities Roundup: Market Talk

17 okt 2025, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

17 okt 2025, 20:34 UTC

Marktinformatie

Deere Is Reaching the End of Its Downcycle -- Market Talk

17 okt 2025, 20:27 UTC

Marktinformatie

Soft Growth Ahead in Canada But Not Far Off From Potential GDP, Macklem Says -- Market Talk

17 okt 2025, 19:46 UTC

Marktinformatie

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

17 okt 2025, 19:45 UTC

Marktinformatie

Oil Futures Stabilize, But End Week With A Loss -- Market Talk

17 okt 2025, 18:45 UTC

Marktinformatie

Treasury Yields, Dollar Try to Reclaim Some Ground -- Market Talk

17 okt 2025, 17:51 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

17 okt 2025, 17:51 UTC

Marktinformatie

Euro Still a Long Way From Supplanting Dollar, Former ECB Rate Setter Says -- Market Talk

17 okt 2025, 17:44 UTC

Marktinformatie

EQT Seen With Long-Term Growth Opportunities -- Market Talk

17 okt 2025, 17:35 UTC

Marktinformatie

U.S. Oil Rig Count Unchanged at 418 -- Market Talk

17 okt 2025, 16:20 UTC

Marktinformatie

Winsten

Tech, Media & Telecom Roundup: Market Talk

17 okt 2025, 16:20 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

17 okt 2025, 16:14 UTC

Marktinformatie

Home Depot Will Gain From Pick Up in Home Improvement Activity -- Market Talk

17 okt 2025, 16:04 UTC

Marktinformatie

Home Improvement Demand Is Starting to Pick Up -- Market Talk

17 okt 2025, 15:58 UTC

Marktinformatie

Amazon's Project Rainier Will Begin to Stem Its AI Share Losses -- Market Talk

17 okt 2025, 15:56 UTC

Winsten

These Stocks Are Moving the Most Today: Zions Bancorp, Jefferies, Amex, Oracle, Novo Nordisk, Lilly, State Street, CSX, and More -- Barrons.com

17 okt 2025, 15:43 UTC

Marktinformatie

Global Equities Roundup: Market Talk

Peer Vergelijking

Prijswijziging

Evolent Health Inc Prognose

Koersdoel

By TipRanks

114.21% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 16.13 USD 114.21%

Hoogste 20 USD

Laagste 9 USD

Gebaseerd op 12 Wall Street-analisten die 12-maands prijsdoelen bieden voor Evolent Health Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

12 ratings

Buy

Hold

Sell

Gebaseerd op 12 analisten die aandelenratings hebben gegeven aan Evolent Health Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

10.33 / 10.95Steun & Weerstand

Recent bullish events outweigh bearish events.

All events are bullish.

All events are bearish.

Sentiment

By Acuity

306 / 371 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.